In this review we describe the current evidence for use of bisphosphonates as part of the adjuvant treatment of patients with early-stage breast cancer.
Maria Cristina Figueroa-magalhães, MD
Advertisement
Articles by Maria Cristina Figueroa-magalhães, MD
Advertisement
Latest Updated Articles
- Bone-Modifying Agents as Adjuvant Therapy for Early-Stage Breast Cancer
Published: October 23rd 2012 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
ESMO 2025: The Top 10 Takeaways That May Shift Oncology Practice
2
Frontline Tislelizumab Combo Improves Long-Term Survival in ES-SCLC
3
ctDNA Status May Determine Adjuvant Immunotherapy Benefit in MIBC
4
FDA Approves Revumenib in R/R NPM1-Mutant AML
5
